Background: Cutaneous Leishmaniasis (CL) in Afghanistan is endemic. Kabul is the world capital of this disease, reporting more than 40% of the total annual incidence. However, under-reporting misleads the real burden: for each detected case, the primary healthcare system misses 3-5 cases. This NTD has the following main impacts:i) stigma and marginalization due to the permanent disabilities (particularly facial disfiguration); ii) quality of life, as the duration of CL is not just limited to the period of the active infection, but can have a life long effect as for disfiguration and disabilities.
展开▼
